Barriers to Volunteer Enrollment in HIV Preventive Vaccine Clinical Research Trials: A Review of the Literature

Journal of the Association of Nurses in AIDS Care

Volumn 22, Issue 4, 2011, Pages 330-334

  Hurley Rosenblatt, Arlene ^a   Dorsen, Caroline ^b  

^a ROCKEFELLER UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY   (United States)

Author keywords

HIV; Recruitment; Research; Vaccine

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATIENT SELECTION;

AIDS VACCINES; HIV INFECTIONS; HUMANS; PATIENT SELECTION;

EID: 79958787613     PISSN: 10553290     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jana.2010.12.001     Document Type: Article

References (10)

1. Allen M.A., Liang T.S., La Salvia T., Tjugum T.B., Gulakowski R.J., Murguia M. Assessing the attitudes, knowledge, and awareness of HIV vaccine research among adults in the United States. Journal of Acquired Immune Deficiency Syndromes 2005, 40:617-624.
2. Allen M., Israel H., Rybczyk K., Pugliese M.A., Loughran K., Wagner L., Erb S. Trial-related discrimination in HIV vaccine clinical trials. AIDS Research and Human Retroviruses 2001, 17:667-674. 10.1089/088922201750236942.
3. Buchbinder S.P., Metch B., Holte S.E., Scheer S., Coletti A., Vittinghoff E. Determinants of enrollment in a preventative HIV vaccine trial: Hypothetical versus actual willingness and barriers to participation. Journal of Acquired Immune Deficiency Syndromes 2004, 36:604-612.
4. Centers for Disease Control and Prevention. (2009). U.S. Public Health Service Syphilis Study at Tuskegee. Retrieved from http://www.cdc.gov/tuskegee/timeline.htm.
5. Esparza J., Osmanov S. Current issues in HIV vaccine development. Journal of Health Management 2000, 2:245-255. 10.1177/097206340000200209.
6. Koblin B.A., Holte S., Lenderking B., Heagerty P. Readiness for HIV vaccine trials: Changes in willingness and knowledge among high-risk populations in the HIV network for prevention trials. Journal of Acquired Immune Deficiency Syndromes 2000, 24:451-457.
7. McCluskey M.M., Alexander S.B., Larkin B.D., Murguia M., Wakefield S. An HIV vaccine: As we build it, will they come?. HIV Vaccine 2005, 24:643-651. 10.1377/hlthaff.24.3.643.
8. Mills E., Cooper C., Gyatt G., Gilchrist A., Rachlis B., Sulway C., Wilson S. Barriers to participating in an HIV vaccine trial: A systematic review. AIDS 2004, 18:2235-2242.
9. Ravanfar P., Mendoza N., Satyaprakash A., Jordan B. HIV vaccines under study. Dermatologic Therapy 2009, 22:158-167. 10.1111/j.1529-8019.2009.01228.x.
10. Strauss R.P., Sengupta S., Kegeles S., McLellan E., Metzger D., Eyre S., MacQueen K.M., et al. Willingness to volunteer in future preventive HIV vaccine trials: Issues and perspectives from three U.S. communities. Journal of Acquired Immune Deficiency Syndromes 2001, 26:63-71.